Stay updated with breaking news from Pharma Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strides Pharma Science posted a net profit of Rs 10.4 crore in Q4FY24, rebounding from a loss of Rs 1 crore in the same period last year. Pre-tax profit was Rs 29.6 crore.
The company's Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food & Drug Administration (USFDA), the drug firm said in a regulatory filing.
Strides Pharma Share Price | It will respond to these observations comprehensively to FDA within the stipulated time, the pharmaceutical firm has said
SBI Mutual Fund picked additional 2.25 lakh shares at same average price in VST Industries
Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 731 in its research report dated December 26, 2023.